CEBP Meeting Calendar Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruce, W. R.
Right arrow Articles by Medline, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruce, W. R.
Right arrow Articles by Medline, A.
Cancer Epidemiology Biomarkers & Prevention Vol. 9, 1271-1279, December 2000
© 2000 American Association for Cancer Research


Review

Possible Mechanisms Relating Diet and Risk of Colon Cancer1

W. Robert Bruce2, Adria Giacca and Alan Medline

Departments of Nutritional Sciences [W. R. B.], Physiology [A. G.], and Laboratory Medicine and Pathobiology [A. M.], University of Toronto, Toronto, Ontario, Canada M5S 3E2

Two recent developments in cancer epidemiology and experimental carcinogenesis provide the basis for two possible mechanisms relating diet and colon cancer risk. The first development is the accumulating epidemiological evidence for an association between insulin resistance and colonic adenomas and cancers. This evidence suggests the following mechanism: the consumption of excess dietary energy results in the development of insulin resistance with increased circulating levels of insulin, triglycerides, and non-esterified fatty acids. These circulating factors subject colonic epithelial cells to a proliferative stimulus and also expose them to reactive oxygen intermediates. These long-term exposures result in the promotion of colon cancer. The second development is the continuing identification of agents that significantly inhibit experimental colon carcinogenesis. These observations suggest the following mechanism: focal loss of epithelial barrier function resulting from a failure of terminal differentiation results in the "leak" of a presently undefined toxin and a focal inflammatory response characterized by evidence of the activation of the COX-2 enzyme and an oxidative stress with the release of reactive oxygen intermediates. The resulting focal proliferation and mutagenesis give rise to aberrant crypt foci and adenomas. The process is inhibited by: (a) demulcents confined to the colonic lumen that "repair" the surface; (b) anti-inflammatory agents; or (c) anti-oxidants. The two mechanisms, i.e., insulin resistance acting throughout the body and focal epithelial barrier failure acting locally, can describe most of the known relationships between diet and colon cancer risk.




This article has been cited by other articles:


Home page
J DAIRY SCIHome page
D. H. Purohit, A. N. Hassan, E. Bhatia, X. Zhang, and C. Dwivedi
Rheological, sensorial, and chemopreventive properties of milk fermented with exopolysaccharide-producing lactic cultures
J Dairy Sci, March 1, 2009; 92(3): 847 - 856.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. S. Sridhar and P. J. Goodwin
Insulin-Insulin-Like Growth Factor Axis and Colon Cancer
J. Clin. Oncol., January 10, 2009; 27(2): 165 - 167.
[Full Text] [PDF]


Home page
Ann Clin BiochemHome page
K. Kotani, N. Sakane, and A. Gugliucci
The association between Trp64Arg polymorphisms of beta3-adrenergic receptor gene and systemic disorders: a possibility of prevention
Ann Clin Biochem, January 1, 2009; 46(1): 83 - 84.
[Full Text] [PDF]


Home page
J. Nutr.Home page
C. A. Warren, K. J. Paulhill, L. A. Davidson, J. R. Lupton, S. S. Taddeo, M. Y. Hong, R. J. Carroll, R. S. Chapkin, and N. D. Turner
Quercetin May Suppress Rat Aberrant Crypt Foci Formation by Suppressing Inflammatory Mediators That Influence Proliferation and Apoptosis
J. Nutr., January 1, 2009; 139(1): 101 - 105.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Roncucci, E. Mora, F. Mariani, S. Bursi, A. Pezzi, G. Rossi, M. Pedroni, D. Luppi, L. Santoro, S. Monni, et al.
Myeloperoxidase-Positive Cell Infiltration in Colorectal Carcinogenesis as Indicator of Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2291 - 2297.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. C. Vinikoor, J. C. Schroeder, R. C. Millikan, J. A. Satia, C. F. Martin, J. Ibrahim, J. A. Galanko, and R. S. Sandler
Consumption of trans-Fatty Acid and Its Association with Colorectal Adenomas
Am. J. Epidemiol., August 1, 2008; 168(3): 289 - 297.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
R. Maglietta, A. Piepoli, D. Catalano, F. Licciulli, M. Carella, S. Liuni, G. Pesole, F. Perri, and N. Ancona
Statistical assessment of functional categories of genes deregulated in pathological conditions by using microarray data
Bioinformatics, August 15, 2007; 23(16): 2063 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. I. Berndt, W.-Y. Huang, M. D. Fallin, K. J. Helzlsouer, E. A. Platz, J. L. Weissfeld, T. R. Church, R. Welch, S. J. Chanock, and R. B. Hayes
Genetic Variation in Base Excision Repair Genes and the Prevalence of Advanced Colorectal Adenoma
Cancer Res., February 1, 2007; 67(3): 1395 - 1404.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E E Frezza, M S Wachtel, and M Chiriva-Internati
Influence of obesity on the risk of developing colon cancer
Gut, February 1, 2006; 55(2): 285 - 291.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Seow, J.-M. Yuan, W.-P. Koh, H.-P. Lee, and M. C. Yu
Diabetes Mellitus and Risk of Colorectal Cancer in the Singapore Chinese Health Study
J Natl Cancer Inst, January 18, 2006; 98(2): 135 - 138.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Suzuki, Y. Ito, K. Wakai, M. Kawado, S. Hashimoto, H. Toyoshima, M. Kojima, S. Tokudome, N. Hayakawa, Y. Watanabe, et al.
Serum Oxidized Low-Density Lipoprotein Levels and Risk of Colorectal Cancer: A Case-Control Study Nested in the Japan Collaborative Cohort Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1781 - 1787.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
U. Wenzel, A. Nickel, S. Kuntz, and H. Daniel
Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions
Carcinogenesis, May 1, 2004; 25(5): 703 - 712.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Chen, G. Shen, V. Hebbar, R. Hu, E. D. Owuor, and A.-N.T. Kong
Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells
Carcinogenesis, August 1, 2003; 24(8): 1369 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. H. Saydah, C. M. Loria, M. S. Eberhardt, and F. L. Brancati
Abnormal Glucose Tolerance and the Risk of Cancer Death in the United States
Am. J. Epidemiol., June 15, 2003; 157(12): 1092 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. R. Bruce
Counterpoint: From Animal Models to Prevention of Colon Cancer. Criteria for Proceeding from Preclinical Studies and Choice of Models for Prevention Studies
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 401 - 404.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. H. Saydah, E. A. Platz, N. Rifai, M. N. Pollak, F. L. Brancati, and K. J. Helzlsouer
Association of Markers of Insulin and Glucose Control with Subsequent Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 412 - 418.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. Komninou, A. Ayonote, J. P. Richie Jr., and B. Rigas
Insulin Resistance and Its Contribution to Colon Carcinogenesis
Experimental Biology and Medicine, April 1, 2003; 228(4): 396 - 405.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
P. M. Brauer, G. E. McKeown-Eyssen, V. Jazmaji, A. G. Logan, D. F. Andrews, D. Jenkins, N. Marcon, F. Saibil, L. Cohen, H. Stern, et al.
Familial Aggregation of Diabetes and Hypertension in a Case-Control Study of Colorectal Neoplasia
Am. J. Epidemiol., October 15, 2002; 156(8): 702 - 713.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
P D Terry, A B Miller, and T E Rohan
Obesity and colorectal cancer risk in women
Gut, August 1, 2002; 51(2): 191 - 194.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. S. Sandhu, D. B. Dunger, and E. L. Giovannucci
Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal Cancer
J Natl Cancer Inst, July 3, 2002; 94(13): 972 - 980.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
F Levi, C Pasche, F Lucchini, C La Vecchia, M S Sandhu, and K-T Khaw
Diabetes mellitus, family history, and colorectal cancer
J Epidemiol Community Health, June 1, 2002; 56(6): 479 - 480.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. A. Colangelo, S. M. Gapstur, P. H. Gann, A. R. Dyer, and K. Liu
Colorectal Cancer Mortality and Factors Related to the Insulin Resistance Syndrome
Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 385 - 391.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.